Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-6,819
Closed -$146K 1979
2022
Q2
$146K Buy
6,819
+3,271
+92% +$90.7K 0.01% 1075
2022
Q1
$131K Buy
+3,548
New +$138K ﹤0.01% 1086
2021
Q4
Sell
-6,322
Closed -$401K 1946
2021
Q3
$401K Buy
+6,322
New +$481K 0.01% 981
2019
Q4
Sell
-1,415
Closed -$32K 1177
2019
Q3
$32K Buy
1,415
+1,294
+1,069% +$35.8K 0.01% 645
2019
Q2
$4K Sell
121
-88
-42% -$2.82K ﹤0.01% 945
2019
Q1
$7K Buy
+209
New +$6.09K ﹤0.01% 784
2018
Q4
Sell
-395
Closed -$11K 923
2018
Q3
$11K Sell
395
-457
-54% -$8.55K ﹤0.01% 652
2018
Q2
$10K Buy
+852
New +$9.77K ﹤0.01% 649

Other funds holding CDNA

Point72 Hong Kong's CDNA Position: Q3 2022 in Review

Point72 Hong Kong sold out of CareDx (CDNA) in Q3 2022, closing a stake of 6,819 shares — an estimated $146K sold.

Point72 Hong Kong first reported a position in CDNA in Q2 2018 and held it in 8 quarters. The position peaked at $401K in Q3 2021. 182 funds tracked by Wall St. Rank hold CDNA as of Q3 2022.

  • Point72 Hong Kong reported no remaining CareDx position as of Q3 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 6,819 CareDx shares in Q3 2022, an estimated $146K.
  • Point72 Hong Kong first reported a position in CareDx in Q2 2018 and held it in 8 quarters.
  • Point72 Hong Kong's CareDx position peaked at $401K in Q3 2021.
  • 182 funds tracked by Wall St. Rank held CareDx as of Q3 2022.

Based on Point72 Hong Kong's 13F filing for Q3 2022, filed 14 Nov 2022.